Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
Yiling Pharmaceutical and Shunteng International agree to cooperate on product sales and registration
Yiling Pharmaceutical and Shunteng International reached a cooperation arrangement under which Yiling would introduce Shunteng products for sale in mainland China, while Shunteng would assist with registering Yiling's patented Chinese medicine products in Hong Kong and support their sale through its local retail network.
2020
Yiling Pharmaceutical reports 2020 half-year results
Yiling Pharmaceutical disclosed its 2020 half-year results, reporting revenue of 4.487 billion yuan and net profit attributable to shareholders of 714 million yuan for the reporting period.
2020
Lianhua Qingke tablets receive marketing approval
China's National Medical Products Administration approved production of Lianhua Qingke tablets, an innovative traditional Chinese medicine submitted by Yiling Pharmaceutical.
2020
Yiling Pharmaceutical project wins China's National Science and Technology Progress First Prize
A project completed with Wu Yiling as its principal researcher, on constructing the collateral-disease theory and applying it to prevention and treatment of microvascular disease, received China's 2019 National Science and Technology Progress First Prize. The article identifies Yiling Pharmaceutical as the award recipient.
2019
Yiling Pharmaceutical wins 2019 public-welfare innovation award
Yiling Pharmaceutical received the 2019 China Listed Companies Public Welfare Innovation Award at the Golden Intelligence Awards ceremony held in Beijing.